{"id":991,"date":"2025-12-01T15:54:18","date_gmt":"2025-12-01T14:54:18","guid":{"rendered":"https:\/\/www.madadvising.com\/project\/theravectys\/"},"modified":"2026-04-30T15:32:58","modified_gmt":"2026-04-30T13:32:58","slug":"theravectys","status":"publish","type":"project","link":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/","title":{"rendered":"Theravectys"},"content":{"rendered":"\n<p>Founded in 2005 by Pierre Charneau and his team, Theravectys is a French biotech company spun off from the Pasteur Institute, specialising in therapeutic vaccines and immuno-oncology based on lentiviral vectors. Building on more than twenty years of fundamental and translational research, it develops breakthrough technologies to target certain cancers and infectious diseases. Adrien Dassault participated in a fundraising campaign to support their scientific progress. The company remains an ambitious player in French biotechnology.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Founded in 2005 by Pierre Charneau and his team, Theravectys is a French biotech company spun off from the Pasteur Institute, specialising in therapeutic vaccines and immuno-oncology based on lentiviral vectors. Building on more than twenty years of fundamental and translational research, it develops breakthrough technologies to target certain cancers and infectious diseases. Adrien Dassault [&hellip;]<\/p>\n","protected":false},"featured_media":980,"template":"single-project-2","sector":[20],"class_list":["post-991","project","type-project","status-publish","has-post-thumbnail","hentry","sector-healthcare"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Theravectys - Mad Advising<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theravectys - Mad Advising\" \/>\n<meta property=\"og:description\" content=\"Founded in 2005 by Pierre Charneau and his team, Theravectys is a French biotech company spun off from the Pasteur Institute, specialising in therapeutic vaccines and immuno-oncology based on lentiviral vectors. Building on more than twenty years of fundamental and translational research, it develops breakthrough technologies to target certain cancers and infectious diseases. Adrien Dassault [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/\" \/>\n<meta property=\"og:site_name\" content=\"Mad Advising\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-30T13:32:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/\",\"url\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/\",\"name\":\"Theravectys - Mad Advising\",\"isPartOf\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg\",\"datePublished\":\"2025-12-01T14:54:18+00:00\",\"dateModified\":\"2026-04-30T13:32:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage\",\"url\":\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg\",\"contentUrl\":\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.madadvising.com\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theravectys\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.madadvising.com\/en\/#website\",\"url\":\"https:\/\/www.madadvising.com\/en\/\",\"name\":\"Mad Advising\",\"description\":\"Building Bridges\",\"publisher\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.madadvising.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.madadvising.com\/en\/#organization\",\"name\":\"Mad Advising\",\"url\":\"https:\/\/www.madadvising.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.madadvising.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/05\/logo-colors.svg\",\"contentUrl\":\"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/05\/logo-colors.svg\",\"width\":278,\"height\":63,\"caption\":\"Mad Advising\"},\"image\":{\"@id\":\"https:\/\/www.madadvising.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theravectys - Mad Advising","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/","og_locale":"en_US","og_type":"article","og_title":"Theravectys - Mad Advising","og_description":"Founded in 2005 by Pierre Charneau and his team, Theravectys is a French biotech company spun off from the Pasteur Institute, specialising in therapeutic vaccines and immuno-oncology based on lentiviral vectors. Building on more than twenty years of fundamental and translational research, it develops breakthrough technologies to target certain cancers and infectious diseases. Adrien Dassault [&hellip;]","og_url":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/","og_site_name":"Mad Advising","article_modified_time":"2026-04-30T13:32:58+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/","url":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/","name":"Theravectys - Mad Advising","isPartOf":{"@id":"https:\/\/www.madadvising.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage"},"image":{"@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg","datePublished":"2025-12-01T14:54:18+00:00","dateModified":"2026-04-30T13:32:58+00:00","breadcrumb":{"@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.madadvising.com\/en\/project\/theravectys\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#primaryimage","url":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg","contentUrl":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/12\/theravecyts.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.madadvising.com\/en\/project\/theravectys\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.madadvising.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Theravectys"}]},{"@type":"WebSite","@id":"https:\/\/www.madadvising.com\/en\/#website","url":"https:\/\/www.madadvising.com\/en\/","name":"Mad Advising","description":"Building Bridges","publisher":{"@id":"https:\/\/www.madadvising.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.madadvising.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.madadvising.com\/en\/#organization","name":"Mad Advising","url":"https:\/\/www.madadvising.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.madadvising.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/05\/logo-colors.svg","contentUrl":"https:\/\/www.madadvising.com\/wp-content\/uploads\/2025\/05\/logo-colors.svg","width":278,"height":63,"caption":"Mad Advising"},"image":{"@id":"https:\/\/www.madadvising.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/project\/991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/types\/project"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/media\/980"}],"wp:attachment":[{"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/media?parent=991"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.madadvising.com\/en\/wp-json\/wp\/v2\/sector?post=991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}